Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Beutels

Showing results (71-80 of 254) with videos related to

Pageof 26
Sort By:
Pharmacoeconomics|December 21, 2004
Valuing prevention through economic evaluation: some considerations regarding the choice of discount model for health effects with focus on infectious diseasesJasper M Bos, Philippe Beutels, Lieven Annemans, et al.
Vaccine|November 15, 2016
Inferring rubella outbreak risk from seroprevalence data in BelgiumSteven Abrams, Eleni Kourkouni, Martine Sabbe, et al.
Vaccine|March 13, 2019
Drivers of vaccine decision-making in South Africa: A discrete choice experimentFrederik Verelst, Roselinde Kessels, Wim Delva, et al.
Expert Review of Vaccines|January 9, 2004
Methodological issues and new developments in the economic evaluation of vaccinesPhilippe Beutels, Eddy Van Doorslaer, Pierre Van Damme, et al.
European Journal of Public Health|July 2, 2013
Kicking against the pricks: vaccine sceptics have a different social orientationJeroen Luyten, Pieter Desmet, Veronica Dorgali, et al.
Plos Computational Biology|May 14, 2016
Estimating Time of Infection Using Prior Serological and Individual Information Can Greatly Improve Incidence Estimation of Human and Wildlife InfectionsBenny Borremans, Niel Hens, Philippe Beutels, et al.
Human Vaccines & Immunotherapeutics|February 29, 2012
What counts in cytometric analysis to document vaccine immunogenicity?Benson Ogunjimi, Viggo Van Tendeloo, Pierre Van Damme, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 8, 2011
Imputing QALYs from single time point health state descriptions on the EQ-5D and the SF-6D: a comparison of methods for hepatitis a patientsJeroen Luyten, Christiaan Marais, Niel Hens, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|July 7, 2020
A Computationally Efficient Method for Probabilistic Parameter Threshold Analysis for Health Economic EvaluationsZoë Pieters, Mark Strong, Virginia E Pitzer, et al.
Vaccine|April 13, 2019
An ODE-based mixed modelling approach for B- and T-cell dynamics induced by Varicella-Zoster Virus vaccines in adults shows higher T-cell proliferation with Shingrix than with VarilrixNina Keersmaekers, Benson Ogunjimi, Pierre Van Damme, et al.
Pageof 26

Showing results (71-80 of 254) with videos related to

Sort By:
Pageof 26
Pharmacoeconomics|December 21, 2004
Valuing prevention through economic evaluation: some considerations regarding the choice of discount model for health effects with focus on infectious diseasesJasper M Bos, Philippe Beutels, Lieven Annemans, et al.
Vaccine|November 15, 2016
Inferring rubella outbreak risk from seroprevalence data in BelgiumSteven Abrams, Eleni Kourkouni, Martine Sabbe, et al.
Vaccine|March 13, 2019
Drivers of vaccine decision-making in South Africa: A discrete choice experimentFrederik Verelst, Roselinde Kessels, Wim Delva, et al.
Expert Review of Vaccines|January 9, 2004
Methodological issues and new developments in the economic evaluation of vaccinesPhilippe Beutels, Eddy Van Doorslaer, Pierre Van Damme, et al.
European Journal of Public Health|July 2, 2013
Kicking against the pricks: vaccine sceptics have a different social orientationJeroen Luyten, Pieter Desmet, Veronica Dorgali, et al.
Plos Computational Biology|May 14, 2016
Estimating Time of Infection Using Prior Serological and Individual Information Can Greatly Improve Incidence Estimation of Human and Wildlife InfectionsBenny Borremans, Niel Hens, Philippe Beutels, et al.
Human Vaccines & Immunotherapeutics|February 29, 2012
What counts in cytometric analysis to document vaccine immunogenicity?Benson Ogunjimi, Viggo Van Tendeloo, Pierre Van Damme, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 8, 2011
Imputing QALYs from single time point health state descriptions on the EQ-5D and the SF-6D: a comparison of methods for hepatitis a patientsJeroen Luyten, Christiaan Marais, Niel Hens, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|July 7, 2020
A Computationally Efficient Method for Probabilistic Parameter Threshold Analysis for Health Economic EvaluationsZoë Pieters, Mark Strong, Virginia E Pitzer, et al.
Vaccine|April 13, 2019
An ODE-based mixed modelling approach for B- and T-cell dynamics induced by Varicella-Zoster Virus vaccines in adults shows higher T-cell proliferation with Shingrix than with VarilrixNina Keersmaekers, Benson Ogunjimi, Pierre Van Damme, et al.
Pageof 26